Tower Research Capital LLC (Trc) Benitec Biopharma Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.19 - $0.36 $18 - $34	-96 Reduced 1.27%	7,465 $1,000
Q4 2022 Feb 10, 2023	SELL	$0.13 - $5.95 $25 - $1,154	-194 Reduced 2.5%	7,561 $1,000
Q3 2022 Nov 10, 2022	BUY	$0.31 - $6.32 $1,211 - $24,692	3,907 Added 101.53%	7,755 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.74 - $2.29 $1,667 - $5,161	2,254 Added 141.41%	3,848 $4,000
Q1 2022 May 12, 2022	BUY	$1.96 - $2.96 $3,124 - $4,718	1,594 New	1,594 $4,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.81 $508 - $749	-129 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.59 - $9.26 $334 - $1,194	129 New	129 $1,000

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.